Evidence map›Paper›PMID 22284156›Full record

SynthesisAmerican journal of obstetrics and gynecology2012

Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data.

Roberto Romero, Kypros Nicolaides, Agustin Conde-Agudelo, Ann Tabor, John M O'Brien, Elcin Cetingoz, Eduardo Da Fonseca, George W Creasy, Katharina Klein, Line Rode and 5 more

7 registry-linked trialsOpen access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in American journal of obstetrics and gynecology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 145 papers, 20 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 20 pooled it
32.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00615550 phase3completednot on this map

The Effect of Vaginal Progesterone Administration in the Prevention of Preterm Birth in Women With a Short Cervix [Vaginal Progesterone Bioadhesive Gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix - Trial (PREGNANT Short Cervix - Trial)]

TypeinterventionalSponsorJuniper Pharmaceuticals, Inc.Ran2008 to 2010Enrolled465ConditionsPreterm Delivery, Short Cervix, Short Uterine Cervical LengthArmsprogesterone, placebo
NCT02329535 naterminatednot on this mapstarted 2015, after this paper: background citation

Comparing a Double Dose of Vaginal Progesterone to no Treatment for the Prevention of Preterm Birth in Twins Pregnancy and Short Cervix

TypeinterventionalSponsorHaEmek Medical Center, IsraelRan2015 to 2017Enrolled15ConditionsPremature BirthArmsMicronized progesterone
NCT02490384 naterminatednot on this mapstarted 2015, after this paper: background citation

Randomized Control Trial Physical Exam Indicated Cerclage in Twin Gestations

TypeinterventionalSponsorThomas Jefferson UniversityRan2015 to 2019Enrolled30ConditionsTwin Pregnancy, Antepartum Condition or Complication, Preterm Birth, Cervical Dilation PrematureArmsPhysical exam indicated cerclage
NCT02901626 phase3terminatednot on this mapstarted 2017, after this paper: background citation

A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix

TypeinterventionalSponsorThe George Washington University Biostatistics CenterRan2017 to 2022Enrolled544ConditionsShort Cervix, Preterm DeliveryArmsArabin Cervical Pessary
NCT03058536 phase2 / phase3unknown statusnot on this mapstarted 2017, after this paper: background citation

Progesterone and Cervical Pessary in Twins : A Prospective and Randomized Study to Prevent Preterm Birth (PRECEPT)

TypeinterventionalSponsorMario Henrique Burlacchini de CarvalhoRan2017 to 2019Enrolled312ConditionsPreterm Birth, Twin Pregnancy With Antenatal ProblemArmsArabin Pessary, Vaginal Progesterone, Arabin Pessary and Progesterone
NCT04147117 naunknown statusnot on this mapstarted 2017, after this paper: background citation

Cervical Pessary to Prevent Preterm Singleton Birth in High Risk Population

TypeinterventionalSponsorHospital Sant Joan de DeuRan2017 to 2020Enrolled214ConditionsPreterm BirthArmsCervical pessary
NCT04300322 naunknown statusnot on this mapstarted 2020, after this paper: background citation

The Effectiveness of Cervical Pessary Versus Vaginal Progesterone for the Prevention of Preterm Birth in Women With Singleton Pregnancies and Short Cervix: a Multicenter Randomized Controlled Trial

TypeinterventionalSponsorMỹ Đức HospitalRan2020 to 2022Enrolled804ConditionsPreterm Birth, Short CervixArmsCervical pessary, Vaginal Progesterone
3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 20 syntheses or guidelines pooled it, 577 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2017
    Pooled it
  12. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2016
    Pooled it
  13. 17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis.BJOG : an international journal of obstetrics and gynaecology · 2016
    Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. The prevention, diagnosis and treatment of premature labor.Deutsches Arzteblatt international · 2013
    Pooled it
  20. Pooled it

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 8 countries.

Roberto RomeroPerinatology Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA.
Kypros Nicolaides
Agustin Conde-Agudelo
Ann Tabor
John M O'Brien
Elcin Cetingoz
Eduardo Da Fonseca
George W Creasy
Katharina Klein
Line Rode
Priya Soma-Pillay
Shalini Fusey
Cetin Cam
Zarko Alfirevic
Sonia S Hassan
Eunice Kennedy Shriver Center · USZeynep Kamil Hospital · TRCentral Baptist Hospital · USCopenhagen University Hospital · DKGovernment Medical College and Hospital · INHospital do Servidor Público Estadual · BRKing's College Hospital · GBLiverpool Women's Hospital · GBMedical University of Vienna · ATUniversity of Copenhagen · DKUniversity of Pretoria · ZA

Funding

The Role Of Subclinical Infection And Cytokines In Preterm ParturitionZIAHD002400 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI ROMERO, ROBERTO · 2009 to 2025
$254.4M
Prenatal Diagnosis Of Congenital AnomaliesZIAHD002401 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI ROMERO, ROBERTO · 2009 to 2025
$81.1M
Intramural NIH HHS ZIA HD002401
6 · The paper itself

Abstract

objectiveTo determine whether the use of vaginal progesterone in asymptomatic women with a sonographic short cervix (≤ 25 mm) in the midtrimester reduces the risk of preterm birth and improves neonatal morbidity and mortality. STUDY

designIndividual patient data metaanalysis of randomized controlled trials.

resultsFive trials of high quality were included with a total of 775 women and 827 infants. Treatment with vaginal progesterone was associated with a significant reduction in the rate of preterm birth <33 weeks (relative risk [RR], 0.58; 95% confidence interval [CI], 0.42-0.80), <35 weeks (RR, 0.69; 95% CI, 0.55-0.88), and <28 weeks (RR, 0.50; 95% CI, 0.30-0.81); respiratory distress syndrome (RR, 0.48; 95% CI, 0.30-0.76); composite neonatal morbidity and mortality (RR, 0.57; 95% CI, 0.40-0.81); birthweight <1500 g (RR, 0.55; 95% CI, 0.38-0.80); admission to neonatal intensive care unit (RR, 0.75; 95% CI, 0.59-0.94); and requirement for mechanical ventilation (RR, 0.66; 95% CI, 0.44-0.98). There were no significant differences between the vaginal progesterone and placebo groups in the rate of adverse maternal events or congenital anomalies.

conclusionVaginal progesterone administration to asymptomatic women with a sonographic short cervix reduces the risk of preterm birth and neonatal morbidity and mortality.

Indexed as

Administration, IntravaginalFemaleHumansPregnancyPregnancy Trimester, SecondPremature BirthProgesteroneProgestinsRiskTreatment OutcomeProgesteroneProgestins

Identifiers

PMID22284156
PMCPMC3437773
OpenAlexW2144088431

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.